Maryland Gov. Martin O’Malley said Thursday that a leading Chinese biopharmaceutical company will open a $40 million facility in Montgomery County.
During the first leg of his 10-day trade mission through Asia, O’Malley announced that Tasly Group plans to open a 430,000-square-foot production facility and training center for traditional Chinese medicine in the Shady Grove Life Sciences Center.
“By reaching across borders, we can share knowledge and research, generate promising partnerships, and leverage the power of innovation to create jobs and expand opportunity to make our children winners in this changing, global economy,” the governor said. “We are pleased to welcome Tasly Group to Maryland.”
According to O’Malley, the company selected Maryland to capitalize on a well-entrenched bioscience network, where they will perform clinical trials on traditional Chinese medicine used for coronary disease. The facility is expected to create dozens of jobs over the next three years.
